Authors


Chelsea A. Pizzo, MPH

Latest:

Development of Multipayer Claims-Based Emergency Department Episodes of Care

Thirty-day episodes of care initialized by emergency department visits can inform future quality improvement efforts.


Sushmita Gordhandas, MD

Latest:

Providing Patients With Cancer Access to Affordable Housing During Treatment

Patients traveling for cancer treatment often incur financial burdens. The members of the Alliance of Dedicated Cancer Centers should play a role in mitigating housing-associated costs for patients during cancer treatment.


Cassidy Hixon

Latest:

Updated Clinical Guidelines Outline Optimal Treatment of Helicobacter pylori Infection

For pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.


Lauren E. Sedita, MS

Latest:

Quantifying the Altruism Value for a Rare Pediatric Disease: Duchenne Muscular Dystrophy

Altruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 per year.


Jessica Arguelles, BS

Latest:

Cost-effectiveness of a 3-Year Tele-Messaging Intervention for Positive Airway Pressure Use

Long-term tele-messaging was more effective than no messaging and short-term messaging for positive airway pressure use, and it was highly likely to be cost-effective with an acceptable willingness-to-pay threshold.


Christine Ahn, MBA

Latest:

Modeling Financial Outcomes and Quantifying Risk in Episode-Based Payment Models

This article provides a description of prospective financial simulation methodology and use cases with empirical data for episode-based bundled payments, including implications for contract negotiations and value-based care redesign.


Kimberly Lenz, PharmD, MBA

Latest:

Cost-Benefit Analysis of Sacubitril/Valsartan in a Medicaid Population

The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan.


Josie Cooper, BA

Latest:

Utilization Management and Physician Burnout

This survey assesses physician experiences with utilization management and burnout and investigates whether there is a link between them.


Joanna Bugbee, BBA

Latest:

Screening for Health Literacy, Social Determinants, and Discrimination in Health Plans

This study provides insight on the experiences of patients of a national health plan with 2 structural determinants of health—health care discrimination and health literacy—and how those interact with social determinants of health and patient demographics.


John W. Epling, MD, MSEd

Latest:

A “Sludge Audit” for Health System Colorectal Cancer Screening Services

A systematic, mixed methods “sludge audit” identified novel health system delivery targets for improving colorectal cancer screening services.


Jeffrey Dong, MD

Latest:

Turnover Among New Medicare Advantage Enrollees May Be Greater Than Perceived

Enrollees who join Medicare Advantage undergo significant turnover in the years following enrollment.


Peter Buerhaus, PhD, RN

Latest:

Dual-Eligible Beneficiaries and Inadequate Access to Primary Care Providers

States with the most restrictive scope-of-practice laws have an inadequate supply of primary care clinicians to serve a high concentration of dual-eligible beneficiaries.


Cynthia Sacco, MD

Latest:

Experience Incentivizing Reduction of Racial and Ethnic Disparities in a Medicaid Hospital Quality Incentive Program

Construction of a composite measure, use of a summary disparity statistic, and measure selection are key considerations in the design of equity-focused payment programs.



Erin D. Michos, MD, MHS

Latest:

Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

This study validates the Predicting Risk of CVD Events (PREVENT) score across diverse racial and ethnic populations, highlighting its effectiveness in predicting cardiovascular risk and mortality, regardless of race or ethnicity.


Christopher S. Saigal, MD, MPH

Latest:

Modeling Financial Outcomes and Quantifying Risk in Episode-Based Payment Models

This article provides a description of prospective financial simulation methodology and use cases with empirical data for episode-based bundled payments, including implications for contract negotiations and value-based care redesign.


Chelsea Richwine, PhD, MA

Latest:

Trends in Electronic Health Record Capabilities for Tracking Documentation Time

This study examines trends in hospitals’ access to and use of data from electronic health record (EHR) developers that quantify clinicians’ time spent documenting clinical care in EHRs.



Adam Biener, PhD

Latest:

Recent Cohorts Aging Into Medicare Use More Counseling and Psychotherapy Than Past Cohorts

Adults currently aging into Medicare utilized counseling and psychotherapy services at higher rates than those in prior cohorts at the same age.


Jessica K. DeMartino, PhD

Latest:

Insurer Costs of COVID-19 by Disease Severity and Duration

Payer costs for COVID-19 ranged from a mean of $505 for asymptomatic cases to $126,094 for severe cases with post–COVID-19 condition.


Louie Lu, PhD

Latest:

Digital Musculoskeletal Program Is Associated With Decreased Joint Replacement Rates

Adults with osteoarthritis who took part in a digital musculoskeletal program had lower rates of knee and hip arthroplasty at 12 months vs those using traditional care.


Lili Hu, MD

Latest:

Patient Satisfaction With Letter-Based Communication of LCS Pulmonary Nodule Results

Patients were satisfied with receiving their lung cancer screening (LCS) pulmonary nodule results via letter and considered the amount of information provided in the letter appropriate.


Dr Toon Van Gorp | Image Credit: University of Leuven- stock.adobe.com
Toon Van Gorp, MD, PhD

Latest:

Dr Toon Van Gorp: Mirvetuximab Soravtansine Should Be Global Standard for FRα+ Ovarian Cancer

Toon Van Gorp, MD, PhD, a MIRASOL trial investigator, emphasizes that the final analysis reinforces the efficacy of mirvetuximab soravtansine-gynx (Elahere; AbbVie) in patients with folate receptor alpha-positive (FRα+), platinum-resistant ovarian cancer.


Kathryn Gray, MA

Latest:

Predicting Hospitalizations for Patients With Chronic Kidney Disease

The authors developed an algorithm that uses medical claims to identify patients with chronic kidney disease who are at greatest risk of being hospitalized within 90 days.


Autumn D. Zuckerman, PharmD

Latest:

Rheumatoid Arthritis Medication Adherence in a Health System Specialty Pharmacy

Integrated health system specialty pharmacies provide specialized services to patients, resulting in high rates of adherence to and financial assistance with specialty disease-modifying antirheumatic drugs.


Steven Dean, MD

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Yajun Emily Zhu, MS

Latest:

Treatment Patterns for Patients With Advanced/Metastatic Cancers by Site of Care

Treatment patterns and overall survival were similar regardless of site of care between patients receiving anticancer therapy in the hospital outpatient vs physician office setting.


Ann M. Holmes, PhD

Latest:

The Relationship Between Preventive Dental Care and Overall Medical Expenditures

Using an instrumental variable approach, this study is the first to present causal estimates of the effect of preventive dental visits on overall medical expenditures.


Paul K. Halverson, DrPH

Latest:

Primary Care Case Conferences to Mitigate Social Determinants of Health: A Case Study From One FQHC System

This article describes perceived benefits, facilitators, and challenges of conducting interprofessional team case conferences in primary care settings to address patients’ complex social needs.


Jeremy Gleeson, MD

Latest:

Cold Agglutinin Disease: Clinical Pearls

Take-aways from a discussion on the management of cold agglutinin disease, with expert insight on navigating the healthcare system to optimize patient care.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo